Congenital disorders of glycosylation with defective fucosylation
© 2021 SSIEM..
Fucosylation is essential for intercellular and intracellular recognition, cell-cell interaction, fertilization, and inflammatory processes. Only five types of congenital disorders of glycosylation (CDG) related to an impaired fucosylation have been described to date: FUT8-CDG, FCSK-CDG, POFUT1-CDG SLC35C1-CDG, and the only recently described GFUS-CDG. This review summarizes the clinical findings of all hitherto known 25 patients affected with those defects with regard to their pathophysiology and genotype. In addition, we describe five new patients with novel variants in the SLC35C1 gene. Furthermore, we discuss the efficacy of fucose therapy approaches within the different defects.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Journal of inherited metabolic disease - 44(2021), 6 vom: 13. Nov., Seite 1441-1452 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hüllen, Andreas [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.02.2022 Date Revised 03.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/jimd.12426 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329337467 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329337467 | ||
003 | DE-627 | ||
005 | 20231225204909.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jimd.12426 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329337467 | ||
035 | |a (NLM)34389986 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hüllen, Andreas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Congenital disorders of glycosylation with defective fucosylation |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.02.2022 | ||
500 | |a Date Revised 03.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 SSIEM. | ||
520 | |a Fucosylation is essential for intercellular and intracellular recognition, cell-cell interaction, fertilization, and inflammatory processes. Only five types of congenital disorders of glycosylation (CDG) related to an impaired fucosylation have been described to date: FUT8-CDG, FCSK-CDG, POFUT1-CDG SLC35C1-CDG, and the only recently described GFUS-CDG. This review summarizes the clinical findings of all hitherto known 25 patients affected with those defects with regard to their pathophysiology and genotype. In addition, we describe five new patients with novel variants in the SLC35C1 gene. Furthermore, we discuss the efficacy of fucose therapy approaches within the different defects | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a CDG | |
650 | 4 | |a coarse facial features | |
650 | 4 | |a developmental delay | |
650 | 4 | |a epilepsy | |
650 | 4 | |a fucosylation | |
650 | 4 | |a intellectual disability | |
650 | 4 | |a neutrophilia | |
650 | 7 | |a Glycoproteins |2 NLM | |
650 | 7 | |a Monosaccharide Transport Proteins |2 NLM | |
650 | 7 | |a SLC35C1 protein, human |2 NLM | |
650 | 7 | |a Fucose |2 NLM | |
650 | 7 | |a 28RYY2IV3F |2 NLM | |
700 | 1 | |a Falkenstein, Kristina |e verfasserin |4 aut | |
700 | 1 | |a Weigel, Corina |e verfasserin |4 aut | |
700 | 1 | |a Huidekoper, Hidde |e verfasserin |4 aut | |
700 | 1 | |a Naumann-Bartsch, Nora |e verfasserin |4 aut | |
700 | 1 | |a Spenger, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Feichtinger, René G |e verfasserin |4 aut | |
700 | 1 | |a Schaefers, Jacqueline |e verfasserin |4 aut | |
700 | 1 | |a Frenz, Stephanie |e verfasserin |4 aut | |
700 | 1 | |a Kotlarz, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Momen, Tooba |e verfasserin |4 aut | |
700 | 1 | |a Khoshnevisan, Razieh |e verfasserin |4 aut | |
700 | 1 | |a Riedhammer, Korbinian M |e verfasserin |4 aut | |
700 | 1 | |a Santer, René |e verfasserin |4 aut | |
700 | 1 | |a Herget, Theresia |e verfasserin |4 aut | |
700 | 1 | |a Rennings, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Lefeber, Dirk J |e verfasserin |4 aut | |
700 | 1 | |a Mayr, Johannes A |e verfasserin |4 aut | |
700 | 1 | |a Thiel, Christian |e verfasserin |4 aut | |
700 | 1 | |a Wortmann, Saskia B |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of inherited metabolic disease |d 1978 |g 44(2021), 6 vom: 13. Nov., Seite 1441-1452 |w (DE-627)NLM000432628 |x 1573-2665 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2021 |g number:6 |g day:13 |g month:11 |g pages:1441-1452 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jimd.12426 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2021 |e 6 |b 13 |c 11 |h 1441-1452 |